For instance, in breast cancer, CSCs are commonly identified by the overexpression of surface markers such as CD24, CD29 (β1-intergrin), CD44 (and its variants), CD49f, CD61, CD70, CD90, and CD133. The gene discussed is CD44; the disease is breast carcinoma.